ArticleScientific reports2025
A genetic algorithm-based ensemble model for efficiently identifying interleukin 6 inducing peptides.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- GDA-Pred: Generative AI-Driven Data Augmentation for Improved Prediction of IL-6 and IL-13-Inducing Peptides.International journal of molecular sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Interleukin-6 (IL-6) is a cytokine with diverse biological activities that contribute to a variety of physiologic and immune responses. IL-6-inducing peptides are the short protein fragments that are critical for playing a contributing role in biological processes. Extensive research has advanced the development of IL-6-inducing peptides, but identifying these peptides experimentally remains time-consuming, labor-intensive, and costly. Therefore, computational prediction has gained attention as an alternative method. Meanwhile, some computational methods have already been developed, but they suffer from insufficient accuracy and inadequate feature engineering. In this study, we developed PredIL6, an advanced ensemble learning model that precisely identifies IL-6-inducing peptides by combining probability scores from 148 baseline machine learning and deep learning models, using a genetic algorithm-based meta-classifier. A forward feature selection method was used to construct the ensemble model, which consists of 20 baseline or single-feature models, including AAINDEX, BLOSUM62, and language models (ESM-2 and word2vec). PredIL6 outperformed existing state-of-the-art methods, achieving accuracy values of 0.934 and 0.899 on the training and test sets, respectively. Thus, PredIL6 is a powerful tool for expediting the identification of IL-6-inducing peptides. A freely available web application and a standalone PredIL6 program are provided.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.